|
Volumn 23, Issue 5, 2013, Pages 1310-1314
|
Synthesis and biological evaluation of nucleoside analogues than contain silatrane on the basis of the structure of acyclovir (ACV) as novel inhibitors of hepatitis B virus (HBV)
|
Author keywords
ACV; HBV transgenic mouse; Hepatitis B virus; HepG2.2.15 cell; Silatrane
|
Indexed keywords
ACICLOVIR;
GAMMA INTERFERON;
GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
INTERLEUKIN 2;
LAMIVUDINE;
NUCLEOSIDE DERIVATIVE;
SILATRANE DERIVATIVE;
VIRUS DNA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIVIRAL ACTIVITY;
ARTICLE;
CELL STRAIN HEPG2;
CONTROLLED STUDY;
CYTOTOXICITY TEST;
DRUG DESIGN;
DRUG STRUCTURE;
EVALUATION;
FEMALE;
FLOW CYTOMETRY;
GENE TARGETING;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN CELL;
IC 50;
MALE;
MOUSE;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PROTEIN EXPRESSION;
T LYMPHOCYTE;
TRANSGENIC MOUSE;
ACYCLOVIR;
ANIMALS;
ANTIVIRAL AGENTS;
BICYCLO COMPOUNDS, HETEROCYCLIC;
FEMALE;
HEP G2 CELLS;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
ORGANOSILICON COMPOUNDS;
PURINE NUCLEOSIDES;
RANDOM ALLOCATION;
HEPATITIS B VIRUS;
MUS MUSCULUS;
SIMPLEXVIRUS;
|
EID: 84873728191
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.12.097 Document Type: Article |
Times cited : (32)
|
References (30)
|